Skip to main content

Baker Bros Boosts RYTM Stake to 10.9%

October 10, 2022

The most significant insider activity on today’s list is a 13G filed by Baker Bros Advisors LP.

The hedge fund revealed an increase in ownership from 7.7% to 10.9% in the small-cap biotechnology company Rhythm Pharmaceuticals $RYTM.

This is the largest follow-up purchase Baker Bros has reported since revealing the original position back in 2017.

Baker Bros is now the second-largest shareholder in RYTM.

In another Form 4, Turtle Creek Asset Management reported a purchase of $2.2 million in JELD-WEN Holding $JELD.

Here’s The Hot List, with data through October 7, 2022:

Roivant Sciences Ltd revealed the acquisition of $2.5 million in shares of Immunovant $IMVT.

Two directors for the small-cap REIT Armada Hoffler Properties reported insider buys in a pair of Form 4 filings.

Over in Washington, Senator Richard Blumenthal of Connecticut reported a position in APi Group Corporation $APG.

The only stock that saw bullish options flow was the memory and hard drive manufacturer Western Digital Corporation $WDC.

Stay tuned. We'll be back Tuesday with more insider action.

If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.

And please reach out with any questions. We love hearing from you!

All Star Charts Team

Filed Under: